公开(公告)号：US20220372145A1

公开(公告)日：2022-11-24

申请号：US17876641

申请日：2022-07-29

Applicant: Yeda Research and Development Co. Ltd.

Inventor： Ido AMIT ,  Assaf WEINER ,  Yonatan KATZENELENBOGEN ,  Adam YALIN ,  Fadi SHEBAN

IPC: C07K16/28 ,  C07K16/30

Abstract: A method of reducing the immune suppressor activity of myeloid cells is disclosed. The method comprises contacting myeloid cells with an effective amount of an agent which specifically reduces the amount and/or activity of myeloid cells expressing both Triggering Receptor Expressed On Myeloid Cells 2 (Trem2) and Transmembrane glycoprotein NMB (Gpnmb). The method can be used for treating cancer. Antibodies and bi-specific antibodies are also disclosed.

公开(公告)号：US20240239886A1

公开(公告)日：2024-07-18

申请号：US18432214

申请日：2024-02-05

Applicant: Yeda Research and Development Co. Ltd.

Inventor： Ido AMIT ,  Chamutal BORNSTEIN-OVITS ,  Adam YALIN ,  Adi MOSHE ,  Oren BARBOY ,  Assaf WEINER ,  Yonatan KATZENELENBOGEN ,  Diego JAITIN ,  Fadi SHEBAN

IPC: C07K16/28 ,  A61K35/17 ,  A61K39/00 ,  A61K45/06 ,  A61K47/64 ,  A61P35/00 ,  A61P37/04

CPC classification number: C07K16/2803 ,  A61K35/17 ,  A61K39/4611 ,  A61K39/4631 ,  A61K39/464411 ,  A61K45/06 ,  A61K47/642 ,  A61P35/00 ,  A61P37/04 ,  A61K2039/505 ,  C07K2317/565 ,  C07K2317/71

Abstract: Provided are antibodies to TREM2 and Gpnmb. Also provided are compositions comprising the antibodies and methods of using same.

公开(公告)号：US20220307008A1

公开(公告)日：2022-09-29

申请号：US17619722

申请日：2020-06-16

Applicant: Yeda Research and Development Co. Ltd.

Inventor： Ido AMIT ,  Ido YOFE ,  Diego JAITIN ,  Yonatan KATZENELENBOGEN ,  Mami LENNIKOV ,  Assaf WEINER ,  Hadas KEREN-SHAUL

IPC: C12N15/10 ,  C12Q1/6806 ,  C12N15/11

Abstract: A method of permeabilizing a cell is disclosed. Kits for permeabilizing cells and analysing RNA contents are also disclosed.

公开(公告)号：US20230272484A1

公开(公告)日：2023-08-31

申请号：US18142618

申请日：2023-05-03

Applicant: Yeda Research and Development Co. Ltd. ,  Ichilov Tech Ltd.

Inventor： Ido AMIT ,  Assaf WEINER ,  Mor ZADA ,  Chamutal BORNSTEIN-OVITS ,  Shuang-Yin WANG ,  Yael COHEN

IPC: C12Q1/6886 ,  A61K38/07 ,  A61K31/69 ,  A61K38/13 ,  A61K31/7076 ,  A61P35/00

CPC classification number: C12Q1/6886 ,  A61K38/07 ,  A61K31/69 ,  A61K38/13 ,  A61K31/7076 ,  A61P35/00 ,  C12Q2600/106 ,  C12Q2600/118 ,  C12Q2600/158

Abstract: A method of prognosing a subject diagnosed with multiple myeloma (MM) is provided. Also provided a method of treating a subject diagnosed with MM selected expressing intracellular PPIA and/or RRM2 above a predetermined threshold, the method comprising administering to the subject a therapeutically effective amount of at least one agent which specifically down-regulates activity or expression of PPIA and/or RRM2, thereby treating the subject.

公开(公告)号：US20190194653A1

公开(公告)日：2019-06-27

申请号：US16330774

申请日：2017-09-14

Applicant: Yeda Research and Development Co. Ltd.

Inventor： Ido AMIT ,  Diego JAITIN ,  David LARA-ASTIASO ,  Assaf WEINER ,  Ido YOFE

IPC: C12N15/11 ,  C12N15/10 ,  C12N9/22 ,  C12Q1/6883

CPC classification number: C12N15/11 ,  C12N9/22 ,  C12N15/102 ,  C12N15/1093 ,  C12N15/63 ,  C12N2310/20 ,  C12N2800/80 ,  C12Q1/6883

Abstract: An expression construct is disclosed which comprises: (i) a DNA sequence which encodes at least one guide RNA (gRNA) operatively linked to a transcriptional regulatory sequence so as to allow expression of the gRNA in a target cell; (ii) a barcode sequence for identification of the at least one gRNA operatively linked to a transcriptional regulatory sequence so as to allow expression of the barcode sequence in the target cell.